Ishak Ibrahim

7 Oct 2015

Long governed by separate laws on personal status issues—marriage, divorce, and other family law—Egypt’s Christians are awaiting the government’s latest move. The issue of the personal affairs law for Egypt’s Christians has recently returned to the forefront of national debate in Egypt, with President Abdel-Fattah El Sisi instructing the Cabinet to review a draft law it had previously presented to Egypt’s churches.

EIPR team

13 Sep 2015

Donating one's organs after death can save countless lives and yet it is something not often done in Egypt, despite the harsh reality of the need for organs. Mona Daoud delves into the legalities, societal perceptions, and issues surrounding the health sector when it comes to this vital matter.

“What happens when we die?” This question has been circulating itself amongst the entirety of humanity from the moment it came into existence up to this moment.

EIPR team

21 Jun 2015

Today, one year on from the arrest and detention of human rights lawyer Yara Sallam and 22 peaceful demonstrators, the ICJ calls for their immediate and unconditional release.

On 21 June 2014, Yara Sallam, together with award winning human rights defender Sanaa Seif and 21 others, was arrested and detained in the context of a peaceful demonstration in Heliopolis, Cairo.

Karim Ennarah

29 Mar 2015

 On February 8, 2015, at least 19 fans died while waiting to enter the Air Defense Stadium for the match between Zamalek and ENPPI – it was the first Egyptian league game to allow spectators, albeit a small number, after a three-year ban that was put in place in the wake of the Port Said Stadium disaster which left 72 dead in February 2012. The Air Defense Stadium deaths were caused by a human crush that resulted from the police firing teargas into the very tight entrance where fans were packed before the start of the game.

Ishak Ibrahim

23 Mar 2015

Over the past week, the village of al-Aour in the governorate of Minya—home to thirteen of the twenty Coptic Egyptian victims killed by the Islamic State (ISIS) in Libya—has been transformed. The once obscure village has become a site for official delegations and mourners to visit, and offer condolences and support to the bereaved families of the victims. This influx of visitors is new for al-Aour.

Ishak Ibrahim

23 Mar 2015

The fate of 20 Egyptian Copts, who were kidnapped by masked men in two separate incidents in the Libyan city of Sirte, remains unclear. In the first kidnapping, which took place on December 31, 2014, militants forcefully stopped a microbus transporting Egyptians and kidnapped seven Christians at gunpoint.

Diana El-Tahawy

31 Dec 2014

Egyptian courts have allowed alleged perpetrators of killings and torture from security agencies to walk free, sometimes without ever appearing in court, while relatives of those killed by police brutality suffer in silence.

Bahaa Ezzelarab

12 Jun 2014

On June 5, 2014, an amendment to the Egyptian Penal Code saw the introduction of harassment as a definitive crime. While the amendment does not fully satisfy the aspirations of many stakeholders, who fought for years to enact it (for example, the definition confines harassment to the act of stalking and following the victim, which excludes many acts of verbal harassment), it remains a crucial victory and an achievement worth celebrating.

Yahia Shawkat

28 May 2014

In a previous article I pointed out four main Challenges for the housing minister in Providing adequate housing to the millions of families seeking their right to an affordable and safe home. Challenges One of these was making Government housing projects workTel.

Heba Wanis

25 May 2014

Local newspapers recently reported that the first batch of sofosbuvir, the new drug for treating the hepatitis C virus (HCV), is expected to arrive in August, and the National Committee for the Control of Viral Hepatitis will start identifying the cases that will receive priority treatment.

Sofosbuvir, marketed under the name Sovaldi, is produced by the US-based multinational pharmaceutical company, Gilead Sciences Inc. It is an oral antiviral drug with high cure rates compared to the other antivirals, and is considered a breakthrough in the treatment of HCV.

Pages